Ray did his undergraduate at National Taiwan University and continued to get a master’s degree in Biomedical Engineering at Cornell University. He joined Fred Alt’s lab in Children’s Hospital Boston as a bioinformatician to help develop an analysis pipeline for HTGTS project and picked up basic biological concepts. He then got his Ph.D. under the guidance of Molly Gale Hammel at Cold Spring Harbor Laboratory, where he developed SAKE that provided an easy interface for analyzing NGS/single-cell transcriptomic data. In Scott’s lab, he helps integrate NGS multi-omics data to identify altered targets/pathways.
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Yu-Jui (Ray) Ho discloses the following relationships and financial interests:
No disclosures meeting criteria for time period
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2020 through disclosure submission in spring 2021). This data reflects interests that may or may not still exist. This data is updated annually.